SCHEMBL4853347

SCHEMBL4853347

C=C(CC)C(=O)O.C=C(CC1CO1)C(=O)O

nearest known ligand 0.38

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.38
TET2 Q6N021 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL184079 0.90
SCHEMBL5713286 0.90 ALDH1A1 (0.39) ALDH1A1TET2
Ethylene SCHEMBL10456431 0.88 ALDH1A1 (0.38) ALDH1A1TET2
Methacrylic Acid SCHEMBL27510952 0.86 ALDH1A1 (0.47) ALDH1A1TET2
N,N-Dimethylethanaminium SCHEMBL28284068 0.85 ALDH1A1 (0.36) ALDH1A1
Ethylene Glycol SCHEMBL28327062 0.84 ALDH1A1 (0.36) ALDH1A1TET2
SCHEMBL9766931 0.82 ALDH1A1 (0.35) ALDH1A1
SCHEMBL8512431 0.81 ALDH1A1 (0.36) ALDH1A1
SCHEMBL2724197 0.81 ALDH1A1 (0.47) ALDH1A1
Acrylic Acid SCHEMBL10886312 0.81 ALOX15 (0.48) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10107064-B2 Changeable well seal tool HALLIBURTON ENERGY SERVICES, INC. (US) 2018-10-23 US disclosed
US-20160115759-A1 Changeable Well Seal Tool HALLIBURTON ENERGY SERVICES, INC. 2016-04-28 US disclosed
EP-1591097-B1 Cationically curing two component materials containing a noble metal catalyst MINNESOTA MINING MFG GMBH (DE) 2012-06-20 EP disclosed
US-7368524-B2 Cationically curing two component materials containing a noble metal catalyst 3M INNOVATIVE PROPERTIES COMPANY (US) 2008-05-06 US disclosed
US-20060116445-A1 Cationically curing two component materials containing a noble metal catalyst 3M DEUTSCHLAND GMBH (DE) 2006-06-01 US disclosed
EP-1591097-A1 Cationically curing two component materials containing a noble metal catalyst 3M Espe AG (DE) 2005-11-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060116445-A1 Cationically curing two component materials containing a noble metal catalyst CAD, ELL, MEP1A ALDH1A1 2908/4885TET2 40/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.